Prot #HCRN-GI21-499: NU 21I07: A Phase Ib/II Study of Sotorasib Combined with Chemotherapy for Second Line Treatment of KRAS p. G12C Mutated Advanced Pancreatic Cancer

Mahalingam, Devalingam (PD/PI)

Medicine, Hematology Oncology Division

Project: Research project

Status	Finished
Effective start/end date	6/14/22 → 6/14/25

Funding

Hoosier Cancer Research Network, Inc. ((OE) Prot #HCRN-GI21-499 // (OE) Prot #HCRN-GI21-499)
Amgen, Inc. ((OE) Prot #HCRN-GI21-499 // (OE) Prot #HCRN-GI21-499)